Nodal Tfh lymphoma, PTCL-NOS, and ATLL have the highest proportion of patients with CD5-expressing tumors (>75%), whereas low expression is observed in ENKTL, breast-implant-associated (BIA) ALCL, and hepatosplenic TCL (HSTCL) [129]. Here, CD5 is linked to anaplastic large cell lymphoma.